DexCom, Inc. (DXCM) vs Penumbra, Inc. (PEN)
DexCom, Inc. and Penumbra, Inc. are both Medical Devices companies. DexCom, Inc. is the larger, with a market value of $33.0B against $12.6B — 2.6× the size. DexCom, Inc. trades at the lower P/E: 33.4× against 78.0×. Penumbra, Inc. grew revenue faster over the last twelve months: 17.6% against 15.5%. DexCom, Inc. has the higher net margin (20.1% vs 10.7%) and the higher return on invested capital (37.1% vs 13.1%). Across the 22 metrics below, DexCom, Inc. leads on 14 and Penumbra, Inc. on 8.
Valuation
Profitability
| Metric | DXCM | PEN | Medical Devices median |
|---|---|---|---|
| Gross margin | 62.47% | 67.84% | 56.01% |
| Operating margin | 22.92% | 12.45% | (15.03%) |
| Net margin | 20.12% | 10.67% | (20.40%) |
| Free cash flow margin | 28.27% | 14.35% | (7.24%) |
| Return on equity | 38.49% | 11.37% | (15.32%) |
| Return on assets | 14.51% | 8.80% | (19.72%) |
| Return on invested capital | 37.13% | 13.13% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack